Asston Pharma Board Meeting on July 2, 2026, to Discuss Fund Raising

Asston Pharmaceuticals Ltd has announced a Board of Directors meeting scheduled for July 2, 2026. The primary agenda item is to consider and approve proposals for raising funds through various methods, including preferential issue, subject to necessary regulatory and shareholder approvals. Additionally, the company will close its trading window from June 24, 2026, to July 4, 2026, to prevent insider trading during this period. All connected and designated persons are advised against trading in the company's securities during the window closure.